Nosocomial (hospital-acquired) bloodstream infections continue to complicate the clinical course of critically ill patients and, consequently, to create substantial economic and human costs. These infections may lead to complications in approximately 30% of those patients admitted to an intensive care unit (ICU) and cost an estimated $25,000 per infection. Previous studies have shown that administration of inadequate antimicrobial treatment of bloodstream infections is associated with significantly higher mortality rate; therefore, strategies to limit bloodstream infections in the ICU have been developed to improve patient outcomes. Although healthcare providers are cognizant of measures to control infection, inconsistent application of these measures remain a concern in the ICU.

In this regional dinner meeting, we will present up-to-date information on the risk of acquiring nosocomial bloodstream infections, highlight the most common sites of these infections, and discuss strategies for preventing and controlling bloodstream infections in the ICU. The goals are to enhance awareness and understanding of risks for bloodstream infection and encourage consistent application of infection control measures to promote more favorable outcomes for patients.

Registration and Dinner (30 Minutes)

Introduction and Overview (5 Minutes)
Local Moderator

Management of Invasive Fungal Infections in the ICU (25 Minutes)
Marin Kollef, MD

The Evolving Response to Antibiotic Resistance in the ICU (25 Minutes)
George Karam, MD

Question and Answer Session (30 Minutes)

Program Conclusion (5 Minutes)
Local Moderator

Intended Audience
Infectious disease physicians, hospitalists, internal medicine physicians, critical care and intensive care physicians, and fellows (surgical and medical); hospital pharmacists, ICU PharmDs, and hospital formulary committee directors.

Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Advanced Studies in Medicine (ASiM). PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine (PIM) designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.
(Universal Program Number – 809-999-07-071-L01.)

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Fee Information
There is no fee for this educational activity.